In July, a PubPeer commenter called out a paper in Biochimica et Biophysica Acta for image duplication; by September, the paper was retracted for the exact reason detailed in the anonymous comment.
Here’s the notice for “Effect of ST3GAL 4 and FUT 7 on sialyl Lewis X synthesis and multidrug resistance in human acute myeloid leukemia,” a paper initially published in June: Continue reading PubPeer strikes again: Leukemia paper retracted for image duplications
Last week, we wrote about conservationist Stuart Pimm receiving criticism for casual sexism in a recent book review.
The journal did not retract the review, but it released an editor’s note condemning the language Pimm used, including quoting a movie scene in which a man told a woman “I don’t take whores in taxis.” Some readers have questioned whether this is really an instance of sexism, including here in the Retraction Watch comments.
So we reached out to Amanda Stanley, a conservation scientist who was so troubled by the book review that she wrote a letter to the editor, to be published soon in Biological Conservation. Here’s her powerful explanation of where this fits in the overall conversation about sexism in science:
Continue reading “I’m so done with it”: Conservationist speaks out against sexism in science
The Elsevier journal Biological Conservation has put out an apology, but not a retraction, after outcry over a bizarre, misogynistic non sequitur in a book review by Duke conservation biologist Stuart Pimm.
Here’s the introduction to Pimm’s review of Keeping the Wild: Against the Domestication of Earth, which went online in October ahead of its December print publication: Continue reading ‘‘I don’t take whores in taxis”: Casual sexism in scientific journal leads to editor’s note
The Leadership Quarterly has retracted a trio of papers by Frederick Walumbwa, an “ethical leadership” guru at Florida International University, whose work has come under scrutiny for flawed methodology. And another journal has pulled one of his articles for similar reasons. That brings his count – as far as we can tell — to seven retractions and a mega-correction.
Meanwhile, Arizona State University, Walumbwa’s former employer, has found
that the preponderance of evidence does not support the charge of research misconduct by Dr. Walumbwa…
but that he engaged in “poor research practice.”
The bottom line, according to the Leadership Quarterly, which first announced problems with the articles in February:
Lancet Respiratory Medicine has issued an expression of concern for a meta-analysis on tracheostomy in the intensive care unit that they published earlier this year.
The paper, “Effect of early versus late or no tracheostomy on mortality of critically ill patients receiving mechanical ventilation: a systematic review and meta-analysis“, came from a group at Harvard, Weill Cornell and the University of Athens. The authors purported to find that: Continue reading Lancet journal puts ICU paper on watch after authors acknowledge potentially fatal flaw
Harvard stem cell researcher Doug Melton got a lot of press last year for research on a hormone he named betatrophin, after its supposed ability to increase production of beta cells, which regulate insulin.
Now, the conclusions from that paper, which has been cited 59 times, according to Thomson Scientific’s Web of Knowledge, have been called into question by research from an independent group, as well as follow-up work from the original team.
The interest was driven by the hormone’s potential as a new treatment for diabetes. In 2013, Melton told the Harvard Gazette that betatrophin could be in clinical trials within three to five years. Here’s Kerry Grens in The Scientist: Continue reading “I kind of like that about science:” Harvard diabetes breakthrough muddied by two new papers
Elsevier journal Chemosphere may finally retract a paper it learned contained fabricated data in January when a member of the author’s institution requested the paper be retracted.
The paper has been cited at least once since the lies came to light, as we reported earlier this month.
The journal contacted the relevant parties on October 29 with the following email about “Degradation of 2,4-dinitroanisole (DNAN) by metabolic cooperative activity of Pseudomonas sp. strain FK357andRhodococcus imtechensis strain RKJ300,” although no notice has been posted: Continue reading Will journal finally retract fraudulent paper 10 months after an official request?
A mistake in structure identification has sunk a paper by researchers at the NIH, MIT, and Seoul National University in the Cell Press journal Chemistry and Biology.
Here’s the notice for “Peptide-Based Inhibitors of Plk1 Polo-box Domain Containing Mono-anionic Phosphothreonine Esters and Their Pivaloyloxymethyl Prodrugs”: Continue reading Structure error sinks NIH-MIT-SNU peptide paper
This one’s not a retraction, but rather a back and forth of letters to the editor concerning accusations of plagiarism.
Dentists Bryan and Paul Jacobs, a father and son team, wrote a paper describing a novel surgical technique in March 2013. In October 2013, several Croatian dentists published their own paper using the technique.
A year later, the story has gotten a little more interesting. The November issue of the Journal of Oral and Mixillofacial Surgery, which published the second article, has two letters. One, from the Jacobses, accuses the Croatian authors of plagiarism. The second is a response from author Dragana Gabrić Pandurić, claiming “our real intention was to emphasize, not plagiarize, their work.”
Here’s the letter from Bryan and Paul Jacobs (paywalled): Continue reading “Our real intention was to emphasize, not plagiarize”
The Journal of the American Academy of Dermatology has issued an expression of concern about a 2012 article reporting the experience of military burn unit treating a rare ailment called toxic epidermal necrolysis.
According to the notice, which is behind a paywall (for shame!), the paper appears to have overstated the number of cases the hospital itself has treated of the life-threatening condition: Continue reading Journal expresses concerns over “possible data irregularities” in paper from Army medical center docs